Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases

Autor: Goessens, L., Colombel, J. -F., Outtier, A., Ferrante, M., Sabino, J., Judge, C., Saeidi, R., Rabbitt, L., Armuzzi, A., Domenech, E., Michalopoulos, G., Cremer, A., Garcia-Alonso, F. J., Molnar, T., Karmiris, K., Gecse, K., Van Oostrom, J., Lowenberg, M., Farkas, K., Atreya, R., Ribaldone, D. G., Selinger, C., Hoentjen, F., Bihin, B., Sebastian, S., Rahier, J. -F., Baert, F., Horin, S. B., Bossuyt, P., Mas, E. B., Buckley, M., Byron, C., Coe, C., Doherty, G. A., Dragoni, G., Fernandes, S., Gaya, D. P., Gleeson, S., Keogh, A., Levine, A., Ortega, T. L., Lobo, A. J., Macken, E., Mccarthy, J., Noor, N., O'Toole, A., Posen, A., Privitera, G., Pugliese, D., Raine, T., Reenaers, C., Resal, T., Scarcelli, A., Slattery, E., Strubbe, B., Sugrue, K., Groen, M. T., Vicente, G. T., Truyens, M., Viola, A., Yanai, H., Zulquernain, S. A.

Publikováno v: United European Gastroenterology Journal, 9, 1136-1147
United European Gastroenterology Journal
United European Gastroenterology Journal, 9, 10, pp. 1136-1147
United European gastroenterology journal, 9(10), 1136-1147. SAGE Publications Inc.
United European gastroenterology journal, Vol. 9, no. 10, p. 1136-1147 (2021)
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

BACKGROUND AND AIMS: Few data are available regarding the combination of biologics or small molecules in inflammatory bowel disease (IBD) patients. We report safety and efficacy of such combinations through a retrospective multicentre series. METHODS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98101af1feae0bff43ba358bc7d571b7
https://doi.org/10.1002/ueg2.12170